Changes in planned disease management after piflufolastat F18 PET/CT in men with biochemically recurrent prostate cancer and low PSA levels: A secondary analysis of results from the CONDOR study.
用户P-mPQbgVJoNg
1小时前
9
10
待确认
帖子自动结束时间: 2026-04-07 13:02:28
1. 请及时下载文件确认是否正确, 系统将在 2026-04-09 13:02:31 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1200/JCO.2023.41.6_suppl.61
文献链接: https://ascopubs.org/doi/10.1200/JCO.2023.41.6_suppl.61
其他信息:
出版社: American Society of Clinical Oncology (ASCO)
作者: Frederic Pouliot; Michael A. Gorin; Steven P. Rowe; Lawrence Saperstein; Bela Stephen Denes; Vincent A. DiPippo; Nancy Stambler; Michael J. Morris; Barry A. Siegel
